Document is current
Any future updates will be listed below
-
Authors
Srivastava, Chitrangda
Irshad, Khushboo
Gupta, Yakhlesh
Sarkar, Chitra
Suri, Ashish
Chattopadhyay, Parthaprasad
Sinha, Subrata
Chosdol, Kunzang https://orcid.org/0000-0002-7065-3395
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (5/13/58/2014/NCD-III)
Department of Biotechnology , Ministry of Science and Technology (BT/PR13357/MED/30/1532/2015)
- License Information
-
More Information
Article History
Received: 4 April 2019
Accepted: 5 December 2019
First Online: 28 January 2020
Ethics approval and consent to participate
: •Surgically resected human GBM samples were collected with due patient written consent after approval by Institute Ethics-Committee, AIIMS, New Delhi (Ref. No IESC/T-416/01.11.2013).•ATCC cell lines used in this study have been authenticated by STR cell identification (Project ID: M-1070, Lifecode, New Delhi) on 12th, July, 2016. Cell lines were not infected by mycoplasma.•Approval for use of the cell lines for in-vitro study was received from Institutional Committee on Bio-safety for Recombinant DNA Research, AIIMS, New Delhi, dated 6th April 2015.
: Not Applicable.
: The authors declare that they have no conflict of interest.
